Trials / Recruiting
RecruitingNCT06435195
Clinical Characteristics and Analysis of Pituitary Complex and Rare Diseases
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to systematically describe the clinical characteristics and outcomes of patients with pituitary complex and rare diseases at Peking Union Medical College Hospital. The main questions it aims to answer are: * What are the influencing factors and rates of remission? * What are the comorbidities associated with these diseases? * What are the perioperative events, radiological findings, and pathological features? Researchers will compare different patient groups to see if there are significant differences in these outcomes. Participants will: * Undergo detailed clinical evaluations. * Provide medical history and data for analysis. * Participate in follow-up assessments to monitor disease progression and treatment outcomes.
Detailed description
The study aims to provide a comprehensive analysis of pituitary complex and rare diseases at Peking Union Medical College Hospital. By leveraging a large cohort, the research will explore various clinical characteristics and outcomes. Specifically, the study will examine influencing factors and rates of remission, the presence of comorbidities, and perioperative events. Additionally, it will evaluate radiological findings and pathological features to better understand these conditions. Through this detailed investigation, the study seeks to enhance knowledge and inform clinical practice regarding the management and prognosis of pituitary complex and rare diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Surgical Removal | Resection of pituitary pathologies. |
| PROCEDURE | Biopsy | Taking a small tissue or liquid sample from the pituitary pathologies and the affected area for examination and diagnosis |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2026-09-01
- Completion
- 2026-12-01
- First posted
- 2024-05-30
- Last updated
- 2024-05-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06435195. Inclusion in this directory is not an endorsement.